GEODE CAPITAL MANAGEMENT, LLC

Position in ASND — Ascendis Pharma A/S

CIK 1214717 BOSTON, MA

Position in ASND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$16,683,794

+$2,001,154 QoQ

Shares Held

72,941

+5.9% QoQ

Ownership

0.111%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. ASND ranks #130 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,683,794	72,941	+5.9%	Shares	Defined	2026-05-15
2025-12-31	$14,682,640	68,855	+1.2%	Shares	Defined	2026-02-09
2025-09-30	$13,528,622	68,048	+11.9%	Shares	Defined	2025-11-12
2025-06-30	$10,494,770	60,804	+5.1%	Shares	Defined	2025-08-08
2025-03-31	$9,016,656	57,851	+1.4%	Shares	Defined	2025-05-13
2024-12-31	$7,857,790	57,077	+1.1%	Shares	Defined	2025-02-12
2024-09-30	$8,428,250	56,448	-2.3%	Shares	Defined	2024-11-12
2024-06-30	$7,880,854	57,786	+3.0%	Shares	Defined	2024-08-09
2024-03-31	$8,480,939	56,102	+1.8%	Shares	Defined	2024-05-13
2023-12-31	$6,938,585	55,090	+1.0%	Shares	Defined	2024-02-13
2023-09-30	$5,108,530	54,555	+1.8%	Shares	Defined	2023-11-13
2023-06-30	$4,780,676	53,565	+3.5%	Shares	Defined	2023-08-11
2023-03-31	$5,546,812	51,733	+1.1%	Shares	Defined	2023-05-15
2022-12-31	$6,252,078	51,192	+0.0%	Shares	Defined	2023-02-13
2022-09-30	$5,285,466	51,186	+3.0%	Shares	Defined	2022-11-14
2022-06-30	$4,619,740	49,696	+3.9%	Shares	Defined	2022-08-12
2022-03-31	$5,615,676	47,850	+2.1%	Shares	Defined	2022-05-13
2021-12-31	$6,305,824	46,873	+4.6%	Shares	Defined	2022-02-11
2021-09-30	$7,140,034	44,796	+1.2%	Shares	Defined	2021-11-12
2021-06-30	$5,824,639	44,277	+1.9%	Shares	Defined	2021-08-13
2021-03-31	$5,601,511	43,463	+1.4%	Shares	Defined	2021-05-12
2020-12-31	$7,148,857	42,864	+9.4%	Shares	Defined	2021-02-12
2020-09-30	$6,048,726	39,196	+2.4%	Shares	Defined	2020-11-13
2020-06-30	$5,660,576	38,273	+2.2%	Shares	Defined	2020-08-13
2020-03-31	$4,215,217	37,432	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.